Individual differences in pharmacokinetics and pharmacodynamics of anesthetic agent propofol with regard to CYP2B6 and UGT1A9 genotype and patient age

F Kansaku, T Kumai, K Sasaki, M Yokozuka… - Drug metabolism and …, 2011 - Elsevier
Propofol (2, 6-diisopropylphenol) is administered intravenously for induction and
maintenance of anesthesia; however, cases of progressive myocardial failure (propofol …
被引用次数：51 相关文章

[引用][C] INDIVIDUAL DIFFERENCES IN PHARMACOKINETICS AND PHARMACODYNAMICS OF ANESTHETIC AGENT PROPOFOL WITH REGARD TO CYP2B6 AND …

F KANSAKU, T KUMAI - 2011 - sid.ir

Individual differences in pharmacokinetics and pharmacodynamics of anesthetic agent propofol with regard to CYP2B6 and UGT1A9 genotype and patient age

F Kansaku, T Kumai, K Sasaki, M Yokozuka… - Drug Metabolism and …, 2011 - hero.epa.gov
Abstract Propofol (2, 6-diisopropylphenol) is administered intravenously for induction and
maintenance of anesthesia; however, cases of progressive myocardial failure (propofol …

Individual Differences in Pharmacokinetics and Pharmacodynamics of Anesthetic Agent Propofol with Regard to CYP2B6 and UGT1A9 Genotype and Patient Age

F KANSAKU, T KUMAI, K SASAKI… - Drug Metabolism and …, 2011 - jstage.jst.go.jp
Propofol (2, 6-diisopropylphenol) is administered intravenously for induction and
maintenance of anesthesia; however, cases of progressive myocardial failure (propofol …

Individual Differences in Pharmacokinetics and Pharmacodynamics of Anesthetic Agent Propofol with Regard to CYP2B6 and UGT1A9 Genotype and Patient Age

F Kansaku, T Kumai, K Sasaki, M Yokozuka… - Drug Metabolism and …, 2011 - infona.pl
Propofol (2, 6-diisopropylphenol) is administered intravenously for induction and
maintenance of anesthesia; however, cases of progressive myocardial failure (propofol …

Individual differences in pharmacokinetics and pharmacodynamics of anesthetic agent propofol with regard to CYP2B6 and UGT1A9 genotype and patient age

F Kansaku, T Kumai, K Sasaki… - Drug metabolism …, 2011 - pubmed.ncbi.nlm.nih.gov
Propofol (2, 6-diisopropylphenol) is administered intravenously for induction and
maintenance of anesthesia; however, cases of progressive myocardial failure (propofol …

Individual Differences in Pharmacokinetics and Pharmacodynamics of Anesthetic Agent Propofol with Regard to CYP2B6 and UGT1A9 Genotype and Patient Age

K Fumiyasu, K Toshio, S Kuniharu, Y Makito… - Drug Metabolism and …, 2011 - cir.nii.ac.jp
抄録 Propofol (2, 6-diisopropylphenol) is administered intravenously for induction and
maintenance of anesthesia; however, cases of progressive myocardial failure (propofol …

Individual Differences in Pharmacokinetics and Pharmacodynamics of Anesthetic Agent Propofol with Regard to CYP2B6 and UGT1A9 Genotype and Patient Age

F KANSAKU, T KUMAI, K SASAKI… - Drug Metabolism and …, 2011 - jlc.jst.go.jp
Propofol (2, 6-diisopropylphenol) is administered intravenously for induction and
maintenance of anesthesia; however, cases of progressive myocardial failure (propofol …

Individual differences in pharmacokinetics and pharmacodynamics of anesthetic agent propofol with regard to CYP2B6 and UGT1A9 genotype and patient age.

F Kansaku, T Kumai, K Sasaki, M Yokozuka… - Drug Metabolism and …, 2011 - europepmc.org
Propofol (2, 6-diisopropylphenol) is administered intravenously for induction and
maintenance of anesthesia; however, cases of progressive myocardial failure (propofol …

[引用][C] INDIVIDUAL DIFFERENCES IN PHARMACOKINETICS AND PHARMACODYNAMICS OF ANESTHETIC AGENT PROPOFOL WITH REGARD TO CYP2B6 AND …

F KANSAKU, T KUMAI - 2011 - sid.ir